Sanofi-Aventis Wants F.D.A. to Reconsider Heart Drug
Friday, May 16, 2008 - 16:21
in Health & Medicine
The company said it would resubmit its application for Multaq based on results from a study showing that the drug reduced both hospitalization and death in patients with atrial fibrillation.